Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

RIGLRIGL
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in RIGEL PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 226,780 shares of RIGL (RIGEL PHARMACEUTICALS INC), worth $8.9M as of 2026-Q2. The position was decreased (-48.4% shares). RIGL represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$8.9M

Current Shares

226,780

Total Value Change

+$6.1M

Total Shares Change

+59,845

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
226,780
-48.4%
$8.9M0.0%$39.12
0
2026-Q1
Decreased
439,101
-34.6%
$11.9M0.0%$33.02
0
2025-Q4
Decreased
671,878
-8.8%
$28.8M0.0%$42.83
0
2025-Q3
Increased
737,035
+304.4%
$20.9M0.0%$28.75
46
2025-Q2
Increased
182,249
+206.4%
$3.4M0.0%$19.48
43
2025-Q1
Decreased
59,474
-64.4%
$1.1M0.0%$17.88
0
2024-Q4
New
166,935
-
$2.8M0.0%$16.47
36

Other major holders of RIGL: BlackRock, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used